StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$45.83+0.99 (+2.21%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Pulse Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Pulse Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$83.04M. For fiscal 2025 it was -$76.94M. The highest annual figure on record is -$4.47M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$76.94M–
FY2024Dec 31, 2024-$56.26M–
FY2023Dec 31, 2023-$43.57M–
FY2022Dec 31, 2022-$58.06M–
FY2021Dec 31, 2021-$63.01M–
FY2020Dec 31, 2020-$49.97M–
FY2019Dec 31, 2019-$47.95M–
FY2018Dec 31, 2018-$37.55M–
FY2017Dec 31, 2017-$25.57M–
FY2016Dec 31, 2016-$9.52M–
FY2015Dec 31, 2015-$4.47M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$25.27M–
Q1 FY2026Mar 31, 2026-$19.15M–
Q4 FY2025Dec 31, 2025-$18.25M–
Q3 FY2025Sep 30, 2025-$20.37M–
Q2 FY2025Jun 30, 2025-$20.28M–
Q1 FY2025Mar 31, 2025-$18.04M–
Q4 FY2024Dec 31, 2024-$20.26M–
Q3 FY2024Sep 30, 2024-$13.66M–
Q2 FY2024Jun 30, 2024-$11.73M–
Q1 FY2024Mar 31, 2024-$10.62M–
Q4 FY2023Dec 31, 2023-$12.53M–
Q3 FY2023Sep 30, 2023-$11.25M–
Q2 FY2023Jun 30, 2023-$10.23M–
Q1 FY2023Mar 31, 2023-$9.56M–
Q4 FY2022Dec 31, 2022-$8.75M–
Q3 FY2022Sep 30, 2022-$18.03M–
Q2 FY2022Jun 30, 2022-$14.01M–
Q1 FY2022Mar 31, 2022-$17.27M–
Q4 FY2021Dec 31, 2021-$15.41M–
Q3 FY2021Sep 30, 2021-$14.27M–
Q2 FY2021Jun 30, 2021-$14.81M–
Q1 FY2021Mar 31, 2021-$18.53M–
Q4 FY2020Dec 31, 2020-$13.76M–
Q3 FY2020Sep 30, 2020-$12.91M–
Q4 FY2019Dec 31, 2019-$13.79M–
Q3 FY2019Sep 30, 2019-$11.75M–
Q2 FY2019Jun 30, 2019-$11.36M–
Q1 FY2019Mar 31, 2019-$10.08M–
Q4 FY2018Dec 31, 2018-$8.95M–
Q3 FY2018Sep 30, 2018-$10.76M–
Q2 FY2018Jun 30, 2018-$9.16M–
Q1 FY2018Mar 31, 2018-$8.67M–
Q4 FY2017Dec 31, 2017-$8.70M–
Q3 FY2017Sep 30, 2017-$7.49M–
Q2 FY2017Jun 30, 2017-$6.18M–
Q1 FY2017Mar 31, 2017-$3.20M–
Q4 FY2016Dec 31, 2016-$2.81M–
Q3 FY2016Sep 30, 2016-$2.77M–

More Pulse Biosciences figures

See a number that looks wrong?